150 related articles for article (PubMed ID: 25227808)
1. Associations between the rs6010620 polymorphism in RTEL1 and risk of glioma: a meta-analysis of 20,711 participants.
Wu Y; Tong X; Tang LL; Zhou K; Zhong CH; Jiang S
Asian Pac J Cancer Prev; 2014; 15(17):7163-7. PubMed ID: 25227808
[TBL] [Abstract][Full Text] [Related]
2. The RTEL1 rs6010620 polymorphism and glioma risk: a meta-analysis based on 12 case-control studies.
Du SL; Geng TT; Feng T; Chen CP; Jin TB; Chen C
Asian Pac J Cancer Prev; 2014; 15(23):10175-9. PubMed ID: 25556444
[TBL] [Abstract][Full Text] [Related]
3. Regulator of telomere elongation helicase 1 (RTEL1) rs6010620 polymorphism contribute to increased risk of glioma.
Zhao W; Bian Y; Zhu W; Zou P; Tang G
Tumour Biol; 2014 Jun; 35(6):5259-66. PubMed ID: 24523019
[TBL] [Abstract][Full Text] [Related]
4. The role of the RTEL1 rs2297440 polymorphism in the risk of glioma development: a meta-analysis.
Zhang C; Lu Y; Zhang X; Yang D; Shang S; Liu D; Jiang K; Huang W
Neurol Sci; 2016 Jul; 37(7):1023-31. PubMed ID: 26939676
[TBL] [Abstract][Full Text] [Related]
5. RTEL1 tagging SNPs and haplotypes were associated with glioma development.
Li G; Jin T; Liang H; Zhang Z; He S; Tu Y; Yang H; Geng T; Cui G; Chen C; Gao G
Diagn Pathol; 2013 May; 8():83. PubMed ID: 23683922
[TBL] [Abstract][Full Text] [Related]
6. Association analysis of RTEL1 variants with risk of adult gliomas in a Korean population.
Namgoong S; Cheong HS; Kim JH; Kim LH; Seo JY; Kang SG; Yoon SJ; Kim SH; Chang JH; Shin HD
PLoS One; 2018; 13(11):e0207660. PubMed ID: 30462709
[TBL] [Abstract][Full Text] [Related]
7. Association between regulator of telomere elongation helicase 1 polymorphism and susceptibility to glioma.
Pei S; Zhao F; Liu J; Fu Q; Shang P
Int J Clin Exp Med; 2015; 8(1):690-7. PubMed ID: 25785045
[TBL] [Abstract][Full Text] [Related]
8. Known glioma risk loci are associated with glioma with a family history of brain tumours -- a case-control gene association study.
Melin B; Dahlin AM; Andersson U; Wang Z; Henriksson R; Hallmans G; Bondy ML; Johansen C; Feychting M; Ahlbom A; Kitahara CM; Wang SS; Ruder AM; Carreón T; Butler MA; Inskip PD; Purdue M; Hsing AW; Mechanic L; Gillanders E; Yeager M; Linet M; Chanock SJ; Hartge P; Rajaraman P
Int J Cancer; 2013 May; 132(10):2464-8. PubMed ID: 23115063
[TBL] [Abstract][Full Text] [Related]
9. RTEL1 and TERT polymorphisms are associated with astrocytoma risk in the Chinese Han population.
Jin TB; Zhang JY; Li G; Du SL; Geng TT; Gao J; Liu QP; Gao GD; Kang LL; Chen C; Li SQ
Tumour Biol; 2013 Dec; 34(6):3659-66. PubMed ID: 23812731
[TBL] [Abstract][Full Text] [Related]
10. Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis.
Wu Y; Zhou J; Zhang J; Tang Z; Chen X; Huang L; Liu S; Chen H; Wang Y
Front Oncol; 2023; 13():1180099. PubMed ID: 37746290
[TBL] [Abstract][Full Text] [Related]
11. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk.
Wu Q; Peng Y; Zhao X
Mol Neurobiol; 2016 Sep; 53(7):4397-405. PubMed ID: 26243184
[TBL] [Abstract][Full Text] [Related]
12. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B
J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018
[TBL] [Abstract][Full Text] [Related]
13. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients.
Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM
Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021
[TBL] [Abstract][Full Text] [Related]
14. Association of ERCC1 C8092A and ERCC2 Lys751Gln polymorphisms with the risk of glioma: a meta-analysis.
Xin Y; Hao S; Lu J; Wang Q; Zhang L
PLoS One; 2014; 9(4):e95966. PubMed ID: 24763305
[TBL] [Abstract][Full Text] [Related]
15. Association between telomerase reverse transcriptase rs2736100 polymorphism and risk of glioma.
Zhou P; Wei L; Xia X; Shao N; Qian X; Yang Y
J Surg Res; 2014 Sep; 191(1):156-60. PubMed ID: 24888789
[TBL] [Abstract][Full Text] [Related]
16. Reappraisal of XRCC1 Arg194Trp polymorphism and glioma risk: a cumulative meta-analysis.
Lu JT; Deng AP; Song J; Zhang L; Luo J
Oncotarget; 2017 Mar; 8(13):21599-21608. PubMed ID: 28423490
[TBL] [Abstract][Full Text] [Related]
17. CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility.
Adel Fahmideh M; Lavebratt C; Schüz J; Röösli M; Tynes T; Grotzer MA; Johansen C; Kuehni CE; Lannering B; Prochazka M; Schmidt LS; Feychting M
Carcinogenesis; 2015 Aug; 36(8):876-82. PubMed ID: 26014354
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in telomerase-related genes are associated with an older age at diagnosis in glioma patients: evidence for distinct pathways of gliomagenesis.
Walsh KM; Rice T; Decker PA; Kosel ML; Kollmeyer T; Hansen HM; Zheng S; McCoy LS; Bracci PM; Anderson E; Hsuang G; Wiemels JL; Pico AR; Smirnov I; Molinaro AM; Tihan T; Berger MS; Chang SM; Prados MD; Lachance DH; Sicotte H; Eckel-Passow JE; Wiencke JK; Jenkins RB; Wrensch MR
Neuro Oncol; 2013 Aug; 15(8):1041-7. PubMed ID: 23733245
[TBL] [Abstract][Full Text] [Related]
19. Genetic analysis of the relation of telomere length-related gene (RTEL1) and coronary heart disease risk.
Lu S; Zhong J; Wu M; Huang K; Zhou Y; Zhong Z; Li Q; Zhou H
Mol Genet Genomic Med; 2019 Mar; 7(3):e550. PubMed ID: 30623606
[TBL] [Abstract][Full Text] [Related]
20. Association of the MTHFR C677T polymorphism with primary brain tumor risk.
Xu C; Yuan L; Tian H; Cao H; Chen S
Tumour Biol; 2013 Dec; 34(6):3457-64. PubMed ID: 23846816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
